PREPARATION OF GLUCOKINASE ACTIVATOR FOR ORAL ADMINISTRATION AND METHOD FOR PREPARATION THEREOF Russian patent published in 2020 - IPC A61K9/14 A61K31/4155 A61K47/32 A61P3/10 

Abstract RU 2728824 C1

FIELD: medicine; pharmaceuticals.

SUBSTANCE: group of inventions relates to the field of pharmaceuticals and medicine. First invention is a solid dispersion for treating type I diabetes, type II diabetes, impaired glucose tolerance, fasting blood glucose and hyperglycemia disorders, which contains polymer carrier and activator of gluconase HMS5552, isotopic-labelled analogues or pharmaceutically acceptable salts,

.

Group of inventions also relates to a composition, a tablet and a capsule comprising said solid dispersion, and use of said dispersions, compositions, tablets and capsules for preparing a drug for treating or preventing type I diabetes, type II diabetes, impaired glucose tolerance, fasting blood glucose and hyperglycemia.

EFFECT: group of inventions provides pH-dependent dissolution of the dispersion and dosage forms based thereon.

36 cl, 9 dwg, 14 tbl, 21 ex

Similar patents RU2728824C1

Title Year Author Number
PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED COMPOSITION, CONTAINING GLUCOKINASE ACTIVATOR AND PPAR RECEPTOR ACTIVATOR, AND THEIR PREPARATION METHOD, AND THEIR USE 2019
  • Chen, Li
  • Li, Yongguo
  • Wang, Gaosen
  • Gao, Huisheng
RU2781638C2
PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED COMPOSITION CONTAINING GLUCOKINASE ACTIVATOR AND BIGUANIDE HYPOGLYCEMIC DRUG, AS WELL AS THEIR PREPARATION METHOD, AND THEIR USE 2019
  • Chen, Li
  • Li, Yongguo
  • Wang, Gaosen
RU2780377C2
PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED FORMULATION CONTAINING A GLUCOKINASE ACTIVATOR AND A KATP CHANNEL BLOCKER, METHOD FOR PRODUCTION AND APPLICATION THEREOF 2019
  • Chen, Li
  • Li, Yungo
  • Van, Gaosen
  • Gao, Khuejshen
RU2772875C1
PHARMACEUTICAL COMBINATION, COMPOSITION AND COMPOUND, CONTAINING A GLUCOKINASE ACTIVATOR AND AN ALPHA-GLUCOSIDASE INHIBITOR, METHODS FOR PRODUCTION AND APPLICATION THEREOF 2019
  • Chen, Li
  • Li, Yongguo
  • Wang, Gaosen
  • Gao, Huisheng
RU2775603C2
PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED FORMULATION CONTAINING A GLUCOKINASE ACTIVATOR AND AN SGLT-2 INHIBITOR, AND METHODS FOR PRODUCTION AND APPLICATION THEREOF 2019
  • Chen, Li
  • Li, Yongguo
  • Wang, Gaosen
  • Gao, Huisheng
RU2770043C1
PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED FORMULATION CONTAINING A GLUCOKINASE ACTIVATOR AND A DPP-IV INHIBITOR, AND METHODS FOR PRODUCTION AND APPLICATION THEREOF 2019
  • Chen, Li
  • Li, Yongguo
  • Wang, Gaosen
  • Gao, Huisheng
RU2770775C1
COATED COMPOUND CONTAINING PHARMACEUTICAL AGENT 2004
  • Klokkers Karin
  • Tsell'Ner Marion
  • Rill'Mann Tomas
  • Dauer Andreas
RU2372893C2
DOSAGE FORM IN CAPSULE FORM CONTAINING TABLETS WITH DIMETHYL FUMARATE 2019
  • Ryzhakova Evgeniya Nikolaevna
  • Shilov Maksim Sergeevich
  • Lavrentev Viktor Vyacheslavovich
RU2742745C1
GALENICAL PREPARATIONS OF ORGANIC COMPOUNDS 2010
  • Sabina Desse-Brete
  • Shtefan Khirsh
RU2535090C2
SOLID OR SEMI-LIQUID TIME-RELEASE DOSAGE FORMS 2008
  • Li Der-Jan
  • Shehn' Robert
  • Chehn' Dzhen-Chi
  • Chehn' Vinsent
RU2471480C2

RU 2 728 824 C1

Authors

Chen, Li

Li, Yongguo

Wang, Gaosen

Dates

2020-07-31Published

2017-12-14Filed